Updated: Wednesday, February 17, 2021, 22:32 [IST]
New Delhi, Feb 17: Union minister Harsh Vardhan on Wednesday said 90 lakh doses of coronavirus vaccines have been administered in the country so far. He also said India is supplying COVID-19 vaccines to 23 countries and 40 nations in all have requested for vaccines.
Vardhan was virtually addressing scientists of CSIR-Central Drug Research Institute, Lucknow on the occasion of its 70th Annual Day. As of today, 90 lakh doses of vaccines have been administered in India, and we are supplying vaccines to 23 countries and 40 countries in all have requested the vaccines, Vardhan said.
India has approved two vaccines - Covaxin developed by Bharat Biotech and Covishield from Oxford/AstraZeneca stable being manufactured by the Serum Institute of India - for emergency use in the country. Congratulating the scientists of the institute, Vardhan highlighted that CSIR-CDRI participated in the fight against COVID-19 through its multi-pronged a
Dr Mahavir Prashad joins Sai Life Sciences as VP, Early Phase Process Development
Dr Mahavir Prashad joins Sai Life Sciences as VP, Early Phase Process Development
11 February 2021 | News Dr Prashad is a recognised leader in chemical process R&D and leveraging green chemistry principles and modern technologies in API synthesis. He possesses an excellent scientific track record through 94 publications, 4 review articles, 1 book chapter, 71 patent/applications, and 10 invited lectures at scientific conferences
Source: prnasia.com
Sai Life Sciences announced the addition of Dr Mahavir Prashad, an acknowledged scientific leader and industry veteran, to its scientific leadership team as Vice President of Early Phase Process Development. With over three decades of experience in advanced research, and roles of increasing responsibility in one of the world s leading pharmaceutical companies, Dr Prashad will provide impetus to Sai Life Sciences growing capabilities and help ac
Renommierter wissenschaftlicher Leiter und Novartis-Veteran wechselt zu Sai Life Sciences prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Acknowledged scientific leader and Novartis veteran joins Sai Life Sciences
HYDERABAD, India, Feb. 11, 2021 /PRNewswire/ Sai Life Sciences, one of India s fastest growing Contract Research, Development & Manufacturing Organizations (CRDMOs), today announced the addition of Dr. Mahavir Prashad, an acknowledged scientific leader and industry veteran, to its scientific leadership team as Vice President of Early Phase Process Development. With over three decades of experience in advanced research, and roles of increasing responsibility in one of the world s leading pharmaceutical companies, Dr. Prashad will provide impetus to Sai Life Sciences growing capabilities and help accelerate the drug development programmes of its customers.
Vaccinating Those Who Have Recovered From Covid-19 Is A Wasteful Exercise: Scientists
Scientists believe that natural antibodies produced through infection last longer than the ones produced through vaccines PTI Jeevan Prakash Sharma 2021-02-09T14:40:29+05:30 Vaccinating Those Who Have Recovered From Covid-19 Is A Wasteful Exercise: Scientists outlookindia.com 2021-02-09T14:43:46+05:30
Also read
India has vaccinated over six million healthcare workers within 24 days. Prime Minister Narendra Modi flagged off the first phase of the Covid-19 vaccination drive on January 16. The tally also includes those who contracted the virus and recovered from it in due course of time.
Interestingly, health experts and virologists say that vaccinating a person who has already recovered from Covid-19 is a wasteful exercise as antibodies developed naturally are better and last longer than the ones developed with the help of vaccines.